Tonix Pharmaceuticals Completes Enrollment in Phase 3 Clinical Trial of TNX-102 SL in Fibromyalgia Life Science Investing
Ohr Pharmaceutical Announces Appointment of David Brown, MD as Chair of Phase 3 Clinical Program Steering Committee Life Science Investing
Oligomerix Awarded a Grant for its Alzheimer’s Drug Discovery Program Targeting Tau Oligomers from the National Institutes of Health Biotech Investing
Progenics Licenses PSMA Antibody Technology to Bayer for Development of Alpha-Radiolabeled Therapeutic Antibodies Life Science Investing
Gordagen Reports Top-line Results of US Human Research (Clinical) Study for Muscle Recovery Supplement Life Science Investing
Teva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11 Life Science Investing
Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (Daclizumab) for Treatment of Multiple Sclerosis Biotech Investing
BioQ Pharma Expands U.S. License and Supply Agreement to Commercialize Third Ready-to-Use Infusion Product Life Science Investing
CORRECTING and REPLACING Sucampo Standardizes on Veeva Vault for a Single Source of Truth and Enterprise-wide Capability Biotech Investing
